Search

James Edward Lanter

from Mahopac, NY
Age ~54
Get Report
Also known as:
James E Lanter, James L Lanter, James E Lanther, Jamie E Lanter, Davis E Lanter, Lanter Davis
Related to:
Jeremy W Davis, 38Aisha DavisIshamekia Blackshear, 43Suzanne Mcclung, 60
Connected to:
Brian C Lanter, 61Charles W Lanter, 87Cory W Lanter, 27Curtis B Lanter, 47Frank D Lanter, 55Ginny Lanter, 58Jim D Lanter, 87John D Lanter, 57Karen Lanter, 47Kathy M Lanter, 65

James Lanter Phones & Addresses

  • Mahopac, NY
  • 4531 Rhea Ridge Dr, Blacksburg, VA 24060 (540) 552-6769
  • 1003 Main St, Blacksburg, VA 24060 (540) 953-1140
  • 1003 S Main St #619, Blacksburg, VA 24060 (919) 388-3032
  • 103 S Main St, Blacksburg, VA 24060 (540) 953-1140
  • 2227 Sorrel Ln, Roanoke, VA 24018 (919) 388-3032
  • 2227 Sorrel Ln #SW, Roanoke, VA 24018 (540) 344-4392
  • 309 Coorsdale Dr, Cary, NC 27511 (919) 388-3032
  • 212 Bald Eagle Ln, Cary, NC 27518 (919) 388-3032
  • 45 Elm St #1J, Morristown, NJ 07960
  • Apache Junction, AZ
  • Chicago, IL
  • Wade, NC
  • 4531 Rhea Ridge Dr, Blacksburg, VA 24060 (540) 989-6085

Work

Position: Service Occupations

Professional Records

Lawyers & Attorneys

James Lanter Photo 1

James Lanter - Lawyer

View page
ISLN:
905631613
Admitted:
1973
University:
University of Illinois, B.A., 1968
Law School:
University of Illinois, J.D., 1973

Resumes

Resumes

James Lanter Photo 2

Database Application Developer

View page
Location:
Washington, DC
Work:
Virginia Tech
Database Application Developer
Education:
Virginia Tech Mba
Master of Business Administration, Masters
James Lanter Photo 3

Master Of Business Administration - Mba

View page
Location:
Mahopac, NY
Work:
Virginia Tech
Master of Business Administration - Mba
Education:
Virginia Tech Mba

Publications

Us Patents

7-Heterocyclyl Quinoline And Thieno[2,3-B]Yridine Derivatives Useful As Antagonists Of Gonadotropin Releasing Hormone

View page
US Patent:
6583153, Jun 24, 2003
Filed:
Nov 14, 2001
Appl. No.:
09/992785
Inventors:
Zhihua Sui - Flemington NJ
Mark Macielag - Branchburg NJ
James C. Lanter - Flemington NJ
Assignee:
Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ
International Classification:
A61K 314745
US Classification:
514293, 514312, 514313, 514267, 546 82, 546 83, 546156, 546159, 544250
Abstract:
The present invention is directed to novel 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives of the general formula (I) or (II) wherein all variables are as herein defined, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions associated with gonadotropin releasing hormone (GnRH). The compounds of the invention are antagonists of GnRH, useful in the treatment of the infertility, prostate cancer, benign prostate hyperplasia (BPH) and as contraceptives.

Substituted Pyrrolopyridinone Derivatives Useful As Phosphodiesterase Inhibitors

View page
US Patent:
6635638, Oct 21, 2003
Filed:
May 2, 2001
Appl. No.:
09/847749
Inventors:
Zhihua Sui - Flemington NJ
Mark J. Macielag - Branchburg NJ
Jihua Guan - Raritan NJ
Weiqin Jiang - Bridgewater NJ
James C. Lanter - Flemington NJ
Assignee:
Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ
International Classification:
C07D47104
US Classification:
5142328, 51425303, 514275, 514292, 544126, 544330, 544331, 544361, 546 84
Abstract:
The invention relates to novel pyrrolopyridinone derivatives of the formula (I) or (II): pharmaceutical compositions containing the compounds and their use for the treatment of sexual dysfunction.

7-Heterocyclyl Quinoline And Thieno[2,3-B]Pyridine Derivatives Useful As Antagonists Of Gonadotropin Releasing Hormone

View page
US Patent:
6765011, Jul 20, 2004
Filed:
Apr 3, 2003
Appl. No.:
10/406393
Inventors:
Zhihua Sui - Flemington NJ
Mark Macielag - Branchburg NJ
James C. Lanter - Flemington NJ
Assignee:
Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ
International Classification:
A61K 314365
US Classification:
514293, 514301, 514267, 514312, 514313, 546 83, 546114, 546 82, 546156, 546159, 544250
Abstract:
The present invention is directed to novel 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives of the general formula (I) or (II) wherein all variables are as herein defined, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions associated with gonadotropin releasing hormone (GnRH). The compounds of the invention are antagonists of GnRH, useful in the treatment of the infertility, prostate cancer, benign prostate hyperplasia (BPH) and as contraceptives.

Substituted Pyrrolopyridinone Derivatives Useful As Phosphodiesterase Inhibitors

View page
US Patent:
6818646, Nov 16, 2004
Filed:
Aug 11, 2003
Appl. No.:
10/638901
Inventors:
Zhihua Sui - New Brunswick NJ, 08933
Mark J. Macielag - New Brunswick NJ, 08933
Jihua Guan - New Brunswick NJ, 08933
Weigin Jiang - New Brunswick NJ, 08933
James C. Lanter - New Brunswick NJ, 08933
International Classification:
A61K 314965
US Classification:
514256, 514292, 544242, 546 81
Abstract:
The invention relates to novel pyrrolopyridinone derivatives of the formula (I) or (II): pharmaceutical compositions containing the compounds and their use for the treatment of sexual dysfunction.

2-(Quinolonyl)-Fused Heterocycles As Androgen Receptor Modulators

View page
US Patent:
6858621, Feb 22, 2005
Filed:
Apr 11, 2003
Appl. No.:
10/411687
Inventors:
James C. Lanter - Raritan NJ, US
Zhihua Sui - Raritan NJ, US
James J. Fiordeliso - Raritan NJ, US
Assignee:
Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ
International Classification:
A61K031/44
A61K031/435
C07D455/04
C07D471/04
US Classification:
514291, 514292, 514293, 546 80, 546 81, 546 82, 546 83, 546 84
Abstract:
The present invention is directed to novel 2-(quinolonyl)-fused heterocyclyl derivatives of the general formula (I) wherein R, R, R, R, R, R, Rand Rare as herein defined, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.

N-Heterocyclyl Hydrazides As Neurotrophic Agents

View page
US Patent:
7087628, Aug 8, 2006
Filed:
Oct 4, 2002
Appl. No.:
10/264997
Inventors:
Zhihua Sui - Flemington NJ, US
Mark Macielag - Branchburg NJ, US
James Lanter - Hillsborough NJ, US
Assignee:
Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ
International Classification:
A61K 31/4439
C07D 401/12
US Classification:
514343, 5462791
Abstract:
This invention relates to a series of N-heterocyclyl hydrazides of Formula I,.

Indole Derivatives As Selective Androgen Receptor Modulators (Sarms)

View page
US Patent:
7282507, Oct 16, 2007
Filed:
Apr 1, 2005
Appl. No.:
11/096664
Inventors:
James C. Lanter - Raritan NJ, US
Zhihua Sui - Raritan NJ, US
James J. Fiordeliso - Raritan NJ, US
Weiqin Jiang - Raritan NJ, US
Xuqing Zhang - Raritan NJ, US
Assignee:
Janssen Pharmaceutica N.V.
International Classification:
A61K 31/404
A61K 31/454
C07D 401/04
C07D 209/10
US Classification:
514323, 514414, 546187, 548466
Abstract:
The present invention is directed to novel indole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.

Indole Derivatives As Selective Androgen Receptor Modulator (Sarms)

View page
US Patent:
7288553, Oct 30, 2007
Filed:
Apr 1, 2005
Appl. No.:
11/096673
Inventors:
James C. Lanter - Raritan NJ, US
Zhihua Sui - Raritan NJ, US
James J. Fiordeliso - Raritan NJ, US
Weiqin Jiang - Raritan NJ, US
Xuqing Zhang - Raritan NJ, US
Assignee:
Janssen Pharmaceutica N.V.
International Classification:
C07D 209/12
A61K 31/404
US Classification:
514339, 514415, 5462774, 548454, 548494, 548495, 548505, 548506, 548507, 548509
Abstract:
The present invention is directed to novel indole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
Control profile
James Edward Lanter from Mahopac, NY, age ~54 Get Report